Session  dedicated to epidemic threats, the situation caused by Sars-CoV-2. Strategies for strengthening  research infrastructures and projects related to epidemiological issues.

Discover the research performed in the field of personalized medicine both in oncological and cardiovascular diseases and the involvment of biobanks in these research projects. Clinical trials on biological drugs used in the treatment of most common oncological and cardiovascular disorders will be presented.

The exposome is a term created to describe the entirety of environmental conditions to which living organisms are exposed, from conception and onward throughout life. In this workshop we ask the question… if biobanks are helping research in other –omics, what can biobanks offer as ways to understand the exposome and contribute not just to research, but also to global challenges facing humans and the environment? Please feel warmly welcomed to take part in this workshop, which will be an idea-generating forum and stimulating discussion.”

Interactive session where experts will answer the questions. Impact of GDPR on research, use of human biological material in national and international projects, code of conduct for biobanks.

The session is intended and implementing to show case studies of biobanks working towards or implememting the new ISO standard dedicated to biobanking, 20387.

The session will showcase progress in health research based on the use of prospective population cohorts.

Discover the research performed in the field of personalized medicine both in oncological and cardiovascular diseases and the involvement of biobanks in these research projects. Clinical trials on biological drugs used in the treatment of most common oncological and cardiovascular disorders will be presented.

The session will present the examples of the use of botanical biobanks in environmental research and in agricultural development.

This workshop will look at how we share samples more widely. It has long been a vision, and indeed sometimes it works, but not always. What are the challenges, what are the tools, and what are the breakthrough examples that show the value?

Session related to novel IT solutions including basic challenges such as LIMS systems and also software for data analysis.

AI solutions including data analysis, artificial modelling in biomarker/drug development and imaging technologies.

Business and sustainability models are key for running biobanks, especially those which are funded by projects. The aim of the session is to demonstrate various business models in biobanks from Europe and promote more cooperation between public sector biobanks and industry.

Presentation of educational programmes and courses for biobankers. Understand which international or European courses are being offered.

The session will revisit the patient perspective, our growing experience of biobank life after GDPR, and our emerging view of a biobank code of conduct that suits all.

The session will present the examples of zoological biobanks contributing to species preservation.

A co-produced interactive session from the BBMRI-ERIC Stakeholder Forum, this will feature patients, clinicians and researchers offering different perspectives on issue raised and debated at EBW Antwerp and EBW Lubeck. We will hear from patients who have donated tissue, from researchers who have used those donations in their science to develop new treatments. We will also hear from clinicians who have used new personalised medicines and from patients who have benefited from them. We will explore the challenges in trying to involve patients throughout this process, and learn from good practice examples already established. We will end with a Q&A session to involve the audience too – because at its base, involving patients is all about having conversations, and it’s always good to talk!

Session will present research projects related to orphan diseases, issues regarding collection of biological samples and data.

Session related to all aspects of pre-analytical phase in field of genomics, transcriptomics, proteomics, metabolomics and research performed on microbiome.

The session will highlight examples of biobank-based studies addressing specific disease areas and intended to improve current practice in diagnosis or treatment.

Properly designed business model, appropiate cost calculation is a key component of well managed biobank. Collaboration between biobanks and industry may be another pillar supporting biobank sustainability. This workshop will look at how we share samples more widely between biobanks and academia as well as biobanks and industry. Meet expertes and exchange ideas, share your concerns!

The session will present the cutting-edge ideas, products, or solutions that could impact samples, biobankers, researchers, patients, and downstream add to a healthier world.

This session is dedicated to automation solutions that improve biobank operation.

The session will showcase how museums work with biobanks to understand evolution and species development, and how the biological world has changed during the history of humans.